BAX
BAXTER INTERNATIONAL INC
NYSE · Healthcare · Medical - Instruments & Supplies · US
$24.99
−1.15%Year over year
Reported trailing growth
- Revenue
- +5.4%
- EBITDA
- -27.5%
- EBIT
- —
- EPS
- —
- Free cash flow
- +103.6%
- Operating cash flow
- +72.4%
Forward estimates
Based on analyst estimates
- Revenue
- +2.8%
- EBITDA
- +214.3%
- EPS
- +204.5%
Three-year CAGR
- Revenue
- +3.8%
- EBITDA
- -33.5%
- EBIT
- —
- Net income
- -47.5%
- EPS
- -37.8%
- Free cash flow
- -17.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026